These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 28629749

  • 1. A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.
    Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, Ruiz-Esteves KN, Long LM, Cantave D, Wilson TM, Scott LM, Simakova O, Jung MY, Hahn J, Maric I, Metcalfe DD.
    J Allergy Clin Immunol; 2018 Jan; 141(1):180-188.e3. PubMed ID: 28629749
    [Abstract] [Full Text] [Related]

  • 2. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
    Šelb J, Rijavec M, Eržen R, Zidarn M, Kopač P, Škerget M, Bajrović N, Luzar AD, Park YH, Liu Y, Šerbec VČ, Zver S, Košnik M, Lyons JJ, Korošec P.
    J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
    [Abstract] [Full Text] [Related]

  • 3. Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders.
    Muñoz-González JI, García-Montero AC, Orfao A, Álvarez-Twose I.
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):427-434. PubMed ID: 34298172
    [Abstract] [Full Text] [Related]

  • 4. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.
    Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, Castellani L, Bonetto C, Frattini F, Dama A, Martinelli G, Chilosi M, Senna G, Pizzolo G, Zanotti R.
    J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713
    [Abstract] [Full Text] [Related]

  • 5. Diagnosis of Primary Mast Cell Disorders in Anaphylaxis: Value of KIT D816V in Peripheral Blood.
    De Puysseleyr LP, Ebo DG, Elst J, Faber MA, Poorten MV, Van Gasse AL, Bridts CH, Mertens C, Van Houdt M, Hagendorens MM, Verlinden A, Vermeulen K, Maes MB, Berneman ZN, Sabato V.
    J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3176-3187.e3. PubMed ID: 33975032
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Role of KIT Mutations in Anaphylaxis.
    Coulson E, Zhou S, Akin C.
    Curr Allergy Asthma Rep; 2019 Apr 26; 19(6):31. PubMed ID: 31028494
    [Abstract] [Full Text] [Related]

  • 8. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.
    Broesby-Olsen S, Kristensen T, Vestergaard H, Brixen K, Møller MB, Bindslev-Jensen C, Mastocytosis Centre Odense University Hospital (MastOUH).
    J Allergy Clin Immunol; 2013 Sep 26; 132(3):723-728. PubMed ID: 23587333
    [Abstract] [Full Text] [Related]

  • 9. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.
    Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, Mateo MB, Alonso Díaz de Durana MD, de la Hoz B, Del Pozo Gil MD, Caballero T, Rosado A, Sánchez Matas I, Teodósio C, Jara-Acevedo M, Mollejo M, García-Montero A, Orfao A, Escribano L.
    J Allergy Clin Immunol; 2010 Jun 26; 125(6):1269-1278.e2. PubMed ID: 20434205
    [Abstract] [Full Text] [Related]

  • 10. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
    Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP.
    J Mol Diagn; 2008 Jan 26; 10(1):58-66. PubMed ID: 18165278
    [Abstract] [Full Text] [Related]

  • 11. Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome.
    Wiednig M, Beham-Schmid C, Kranzelbinder B, Aberer E.
    Dermatology; 2013 Jan 26; 227(1):67-71. PubMed ID: 24008407
    [Abstract] [Full Text] [Related]

  • 12. Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes.
    Picard M, Giavina-Bianchi P, Mezzano V, Castells M.
    Clin Ther; 2013 May 26; 35(5):548-62. PubMed ID: 23642289
    [Abstract] [Full Text] [Related]

  • 13. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.
    Wilson TM, Maric I, Simakova O, Bai Y, Chan EC, Olivares N, Carter M, Maric D, Robyn J, Metcalfe DD.
    Haematologica; 2011 Mar 26; 96(3):459-63. PubMed ID: 21134978
    [Abstract] [Full Text] [Related]

  • 14. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
    Zanotti R, Lombardo C, Passalacqua G, Caimmi C, Bonifacio M, De Matteis G, Perbellini O, Rossini M, Schena D, Busa M, Marcotulli MC, Bilò MB, Franchini M, Marchi G, Simioni L, Bonadonna P.
    J Allergy Clin Immunol; 2015 Jul 26; 136(1):135-9. PubMed ID: 25605272
    [Abstract] [Full Text] [Related]

  • 15. The presence of mast cell clonality in patients with unexplained anaphylaxis.
    Gülen T, Hägglund H, Sander B, Dahlén B, Nilsson G.
    Clin Exp Allergy; 2014 Sep 26; 44(9):1179-87. PubMed ID: 25039926
    [Abstract] [Full Text] [Related]

  • 16. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP.
    Leuk Lymphoma; 2003 Feb 26; 44(2):313-9. PubMed ID: 12688351
    [Abstract] [Full Text] [Related]

  • 17. Mast Cell Activation Syndromes: Comparison Between Two Scoring Models to Predict for Mast Cell Clonality.
    Rama TA, Torrado I, Henriques AF, Sánchez-Muñoz L, Jara-Acevedo M, Navarro-Navarro P, Caldas C, Mayado A, Muñoz-González J, García-Montero A, Mollejo M, Redondo E, Garbán A, Moreira A, Órfão A, Álvarez-Twose I.
    J Allergy Clin Immunol Pract; 2023 Mar 26; 11(3):908-919.e4. PubMed ID: 36535520
    [Abstract] [Full Text] [Related]

  • 18. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
    Escande H, Bennani I, Bulai Livideanu C, Uthurriague C, Paul C, Nougué J.
    Ann Dermatol Venereol; 2013 Oct 26; 140(10):641-4. PubMed ID: 24090896
    [Abstract] [Full Text] [Related]

  • 19. Spectrum of mast cell activation disorders.
    Petra AI, Panagiotidou S, Stewart JM, Conti P, Theoharides TC.
    Expert Rev Clin Immunol; 2014 Jun 26; 10(6):729-39. PubMed ID: 24784142
    [Abstract] [Full Text] [Related]

  • 20. Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype.
    Chan EC, Bai Y, Kirshenbaum AS, Fischer ER, Simakova O, Bandara G, Scott LM, Wisch LB, Cantave D, Carter MC, Lewis JC, Noel P, Maric I, Gilfillan AM, Metcalfe DD, Wilson TM.
    J Allergy Clin Immunol; 2014 Jul 26; 134(1):178-87. PubMed ID: 24582309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.